Is Celsius a Buy After Tumbling 18% in 1 Day?

Celsius Holdings reported Q2 revenue of $817.9M (+11% YoY) but adjusted EPS of $0.36 (-23% YoY), with both metrics coming in below consensus. Sales of the flagship Celsius brand fell nearly 12% YoY, underscoring weak demand durability amid fierce competition from Red Bull, Monster, and Kirkland energy drinks. The stock dropped 18% on the results day and now trades about 75% below its March 2024 peak (forward P/E 18.8), keeping the setup risky despite the valuation.

Analysis

CELH looks less like a one-off miss and more like an early warning that shelf velocity in functional energy is normalizing faster than the market expected. In this category, slowing sell-through usually triggers a negative flywheel: retailers cut facings, distributors push harder on promos, and the brand has to spend more just to hold share, which compresses both gross margin and operating leverage over the next 1-3 quarters.

The clearest relative winner is MNST, not because it has faster growth, but because it has the distribution muscle and reset leverage to absorb any share leakage from weaker challengers. COST is a secondary beneficiary through private-label expansion; if Kirkland proves durable, it captures value from a weaker premium subsegment without needing to win the entire category. The risk for the whole space is that challenger fatigue forces a broader re-rating of "growth beverage" names from scarcity multiples to low-growth consumer staples multiples.

The market may be underestimating how quickly these names can rerate when growth decelerates: a move from ~19x forward earnings toward the mid-teens is plausible if the next two quarters confirm stalled brand momentum. The main bullish countercase is that this is a promotional reset rather than permanent share loss, but that requires evidence in scanner data, channel checks, and management commentary on returning velocity. Falsifier: a stabilization in flagship brand sales and margin discipline on the next print; absent that, the path of least resistance remains lower.

Time horizon matters: the next few days are about sentiment and multiple compression, while the next 1-3 months hinge on whether competitors exploit shelf space and whether CELH is forced into heavier discounting. Over 6-18 months, the structural question is whether the brand still has enough differentiation to justify premium valuation versus MNST and retailer-owned alternatives.

Key Decisions for Investors

• Short CELH on any relief rally over the next 1-2 weeks; target a re-test of the post-earnings low with a stop above the pre-earnings gap-fill area. Risk/reward improves if management does not show clear velocity stabilization.
• Pair trade: long MNST / short CELH for 1-3 months. Thesis is relative distribution strength versus a challenger facing shelf contraction; thesis fails if CELH re-accelerates sell-through or MNST loses pricing discipline.
• Add a smaller tactical long COST versus short CELH if you want exposure to private-label substitution. This is a secondary trade, best used only if subsequent retailer checks confirm Kirkland gains are real and not just initial trial.
• Buy CELH put spreads expiring 3-6 months out rather than outright puts if you want defined risk. The trade depends on confirmation of weak channel data; if the next quarter shows better velocity, premium decay will hurt less than straight puts.
• Watch for a guidance reset or margin contraction in the next earnings cycle; if operating margin does not stabilize, this becomes a structural short rather than a tactical trade. Falsifier: improved flagship brand sell-through and reduced promo intensity in the next two quarters.